Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a development stage biotechnology company. The Company is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), an alpha-synucleinopathy. Its proprietary target discovery engine... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > Phase 1 looking good for Lilly except the usual problem
View:
Post by retiredcop on Mar 31, 2023 4:30pm

Phase 1 looking good for Lilly except the usual problem

https://www.reuters.com/business/healthcare-pharmaceuticals/lilly-says-experimental-alzheimers-drug-reduces-amyloid-small-study-2023-03-31/
Comment by retiredcop on Mar 31, 2023 4:33pm
PMN310 Key Features Our PMN310 program is a next-generation, potential best-in-class anti-amyloid therapy in development. Highly selective for only misfolded, toxic oligomers Does not bind monomer Does not bind plaque or vascular deposits Potentially lower risk of amyloid-related imaging abnormality-edema (ARIA-E) (brain swelling) side effect  ...more  
Comment by M101 on Mar 31, 2023 5:54pm
Reminds me of the old door to door salesman who were incapable of hearing the word NO.  But at least you could respect those old liars for their creativity, they weren't all just sociopaths even if they aspired to be (again see Glengarry Glen Ross). But with these guys, with their multi million dollar lobbyists plus the Fauci factor, the only choice is between sociopath and psychopath ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities